---
title: "biote Corp. | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 44.94 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285477121.md"
datetime: "2026-05-07T03:11:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285477121.md)
  - [en](https://longbridge.com/en/news/285477121.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285477121.md)
---

# biote Corp. | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 44.94 M

Revenue: As of FY2026 Q1, the actual value is USD 44.94 M, missing the estimate of USD 46.02 M.

EPS: As of FY2026 Q1, the actual value is USD 0.06, beating the estimate of USD 0.0367.

EBIT: As of FY2026 Q1, the actual value is USD 5.31 M.

### First Quarter 2026 Financial Highlights (YoY Comparison)

#### Revenue

-   Total revenue was $44.9 million, an 8.3% decrease from $49.0 million in the first quarter of 2025.
-   Procedure revenue declined 13.2% to $31.3 million.
-   Dietary supplements revenue grew 19.1% to $11.0 million.

#### Profitability

-   Gross profit margin was 68.9%, compared to 74.3% in the first quarter of 2025.
-   Operating income declined to $3.2 million, from $9.7 million in the first quarter of 2025.
-   Net income was $2.7 million, compared to $15.8 million in the first quarter of 2025.
-   Adjusted EBITDA was $8.7 million, a 36.6% decrease from $13.8 million in the first quarter of 2025.
-   Adjusted EBITDA margin declined to 19.4% from 28.1% in the first quarter of 2025.

#### Operational Costs and Other Items

-   Cost of revenue was $13,982 thousand, compared to $12,610 thousand in the first quarter of 2025.
-   Selling, general and administrative expenses were $27,787 thousand, compared to $26,692 thousand in the first quarter of 2025.
-   Gain from change in fair value of earnout liabilities was $2,149 thousand, compared to $10,688 thousand in the first quarter of 2025.

### Cash Flow (Three Months Ended March 31, 2026 vs 2025)

-   Net cash provided by operating activities was $3,902 thousand, compared to $6,467 thousand in the prior year.
-   Net cash used in investing activities was - $1,168 thousand, compared to - $1,848 thousand in the prior year.
-   Net cash used in financing activities was - $21,539 thousand, compared to - $2,257 thousand in the prior year.
-   Cash and cash equivalents at the end of the period were $5,320 thousand, compared to $41,700 thousand in the prior year.
-   Cash paid for interest was $1,758 thousand, compared to $2,016 thousand in the prior year.
-   Cash paid for income taxes was $120 thousand, compared to $2 thousand in the prior year.

### Balance Sheet (March 31, 2026 vs December 31, 2025)

-   Cash and cash equivalents were $5,320 thousand, down from $24,123 thousand.
-   Total current assets were $36,356 thousand, down from $54,670 thousand.
-   Total assets were $89,032 thousand, down from $107,613 thousand.
-   Inventory, net was $19,881 thousand, up from $19,064 thousand.
-   Total current liabilities were $28,226 thousand, down from $44,991 thousand.
-   Total liabilities were $136,987 thousand, down from $158,010 thousand.

### 2026 Financial Outlook

biote Corp. anticipates revenue to be above $190 million and Adjusted EBITDA to be above $38 million for 2026. Procedure revenue is expected to return to growth in the second half of 2026, though first-half growth is now expected to be moderately lower due to the temporary impact of a voluntary product recall and related supply constraints. Dietary supplements revenue is projected to grow at a mid to high single-digit rate from 2025, consistent with previous guidance.

### Related Stocks

- [BTMD.US](https://longbridge.com/en/quote/BTMD.US.md)

## Related News & Research

- [biote shareholders elect directors and ratify Deloitte appointment](https://longbridge.com/en/news/286825538.md)
- [The Home Depot Announces First Quarter Fiscal 2026 Results; Reaffirms Fiscal 2026 Guidance | HD Stock News](https://longbridge.com/en/news/286890512.md)
- [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md)
- [IDenta Corp Reports its First Quarter 2026 Results, the Strongest Quarter Ever | IDTA Stock News](https://longbridge.com/en/news/286577159.md)
- [Fast Finance Pay Corp Announces First Quarter 2026 Financial Results | FFPP Stock News](https://longbridge.com/en/news/286425407.md)